156 related articles for article (PubMed ID: 11997807)
21. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
[TBL] [Abstract][Full Text] [Related]
22. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
[TBL] [Abstract][Full Text] [Related]
23. Visual fields in retinoblastoma survivors.
Abramson DH; Melson MR; Servodidio C
Arch Ophthalmol; 2004 Sep; 122(9):1324-30. PubMed ID: 15364711
[TBL] [Abstract][Full Text] [Related]
24. Long-term visual outcome following chemoreduction for retinoblastoma.
Demirci H; Shields CL; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
[TBL] [Abstract][Full Text] [Related]
25. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
[TBL] [Abstract][Full Text] [Related]
26. Current treatment of retinoblastoma.
De Potter P
Curr Opin Ophthalmol; 2002 Oct; 13(5):331-6. PubMed ID: 12218465
[TBL] [Abstract][Full Text] [Related]
27. Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma.
Miller DM; Murray TG; Cicciarelli NL; Capo H; Markoe AM
Ophthalmology; 2005 Sep; 112(9):1620-4. PubMed ID: 16024083
[TBL] [Abstract][Full Text] [Related]
28. Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes.
Fabian ID; Naeem Z; Stacey AW; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
Am J Ophthalmol; 2017 Jul; 179():137-144. PubMed ID: 28501391
[TBL] [Abstract][Full Text] [Related]
29. [The efficacy of large spot indirect ophthalmoscopy laser alone or combined with systemic chemotherapy in retinoblastoma therapy].
Liang JH; Cheng Y; Deng X; Yu YY; Li XX
Zhonghua Yan Ke Za Zhi; 2016 Oct; 52(10):745-748. PubMed ID: 27760646
[TBL] [Abstract][Full Text] [Related]
30. Conservative treatment of diffuse infiltrating retinoblastoma: optical coherence tomography-assisted diagnosis and follow-up in three consecutive cases.
Stathopoulos C; Moulin A; Gaillard MC; Beck-Popovic M; Puccinelli F; Munier FL
Br J Ophthalmol; 2019 Jun; 103(6):826-830. PubMed ID: 30049803
[TBL] [Abstract][Full Text] [Related]
31. Surgical repair of rhegmatogenous retinal detachment after treatment for retinoblastoma.
Baumal CR; Shields CL; Shields JA; Tasman WS
Ophthalmology; 1998 Nov; 105(11):2134-9. PubMed ID: 9818618
[TBL] [Abstract][Full Text] [Related]
32. Strabismus in retinoblastoma survivors with long-term follow-up.
Fabian ID; Stacey AW; Naeem Z; Onadim Z; Chowdhury T; Duncan C; Sagoo MS; Reddy MA
J AAPOS; 2018 Aug; 22(4):276.e1-276.e7. PubMed ID: 30009948
[TBL] [Abstract][Full Text] [Related]
33. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
Kobylarz J; Piwowarczyk A; Romanowska-Dixon B; Balwierz W; Dłuzniewska A
Klin Oczna; 2006; 108(1-3):55-9. PubMed ID: 16883942
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
Liu Y; Zhang X; Liu F; Wang KL
Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067
[TBL] [Abstract][Full Text] [Related]
35. Clinical manifestations and treatment of retinoblastoma in Kobe children's hospital for 16 years.
Okimoto S; Nomura K
J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):222-9. PubMed ID: 24844394
[TBL] [Abstract][Full Text] [Related]
36. Rhegmatogenous retinal detachment following treatment for retinoblastoma.
Saumya Pal S; Gopal L; Khetan V; Nagpal A; Sharma T
J Pediatr Ophthalmol Strabismus; 2010; 47(6):349-55. PubMed ID: 20055334
[TBL] [Abstract][Full Text] [Related]
37. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
[TBL] [Abstract][Full Text] [Related]
38. Indocyanine Green-Enhanced Transpupillary Thermotherapy for Retinoblastoma: Analysis of 42 Tumors.
Hasanreisoglu M; Saktanasate J; Schwendeman R; Shields JA; Shields CL
J Pediatr Ophthalmol Strabismus; 2015; 52(6):348-54. PubMed ID: 26584748
[TBL] [Abstract][Full Text] [Related]
39. Outcome of focal treatment to residual retinoblastoma after chemotherapy (Experience with Focal Treatment of Retinoblastoma).
Kashif S; Muhammad K; Siyal N; Adhi MI
J Pak Med Assoc; 2017 Jul; 67(7):1109-1115. PubMed ID: 28770899
[TBL] [Abstract][Full Text] [Related]
40. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
